Clinical Trial Update: A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating enfortumab vedotin in combination with pembrolizumab for muscle-invasive bladder cancer to help preserve the bladder; currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• Padcev (enfortumab vedotin)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Muscle-invasive Bladder Cancer | Phase 2 | Status: RECRUITING